What Medications Are Used to Lower High Cholesterol?

Medically reviewed | Last reviewed: | Evidence level: 1A
High cholesterol (hypercholesterolemia) is treated with medications when lifestyle changes alone are insufficient. Statins are the most commonly prescribed cholesterol-lowering drugs, reducing cardiovascular events by 25-35%. Other options include ezetimibe, PCSK9 inhibitors, fibrates, and bempedoic acid. Understanding your medication options, how they work, and potential side effects helps you work effectively with your healthcare provider for optimal heart health.
📅 Updated:
⏱️ Reading time: 15 minutes
Written and reviewed by iMedic Medical Editorial Team | Specialists in Cardiology

📊 Quick facts about cholesterol medication

Risk Reduction
25-35%
fewer heart attacks with statins
LDL Lowering
30-50%
with high-intensity statins
Muscle Pain
5-10%
experience this side effect
Treatment Duration
Long-term
usually lifelong therapy
Global Use
200+ million
people take statins worldwide
ICD-10 Code
E78.0
Pure hypercholesterolemia

💡 The most important things you need to know

  • Statins are first-line treatment: They reduce LDL cholesterol by 30-50% and significantly lower the risk of heart attack and stroke
  • Most side effects are manageable: Muscle pain affects 5-10% of users, but switching statins or adjusting dose often helps
  • Treatment is typically lifelong: Stopping medication usually causes cholesterol to return to pre-treatment levels
  • Lifestyle changes enhance effectiveness: Diet, exercise, and weight loss work synergistically with medication
  • Multiple drug options exist: If statins don't work or aren't tolerated, ezetimibe, PCSK9 inhibitors, or other drugs are available
  • Never stop without consulting your doctor: Discuss any concerns or side effects before changing your treatment

What Is High Cholesterol and Why Does It Need Treatment?

High cholesterol (hypercholesterolemia) is a condition where there is too much cholesterol in your blood, particularly LDL ("bad") cholesterol. Without treatment, it leads to atherosclerosis, significantly increasing the risk of heart attack and stroke. Medication is needed when lifestyle changes alone cannot reduce cholesterol to safe levels.

Cholesterol is a waxy, fat-like substance that your body needs to build cells, make vitamins, and produce hormones. However, when levels become too high, cholesterol accumulates in the walls of your arteries, forming plaques that narrow and harden the blood vessels. This process, called atherosclerosis, develops slowly over many years but can ultimately lead to life-threatening cardiovascular events.

The liver produces most of the cholesterol your body needs, while the rest comes from foods you eat. Genetics play a significant role in determining how much cholesterol your body produces and how efficiently it removes LDL from the bloodstream. This is why some people have high cholesterol despite eating a healthy diet, while others can maintain normal levels despite less-than-ideal dietary habits.

Understanding the different types of cholesterol is crucial for grasping why treatment matters. Low-density lipoprotein (LDL) is often called "bad" cholesterol because it deposits cholesterol in artery walls. High-density lipoprotein (HDL) is known as "good" cholesterol because it helps remove cholesterol from arteries and transport it back to the liver for elimination. Triglycerides are another type of fat in the blood that can contribute to arterial disease when elevated.

When Is Medication Necessary?

Not everyone with elevated cholesterol requires medication. Treatment decisions are based on your overall cardiovascular risk, not just cholesterol numbers alone. Your doctor will consider multiple factors including your LDL level, presence of diabetes, blood pressure, smoking status, family history of early heart disease, and age.

For people who have already had a heart attack, stroke, or have established cardiovascular disease, cholesterol-lowering medication is almost always recommended regardless of baseline cholesterol levels. This is called secondary prevention. For those without existing heart disease (primary prevention), the decision is more nuanced and depends on calculated 10-year cardiovascular risk.

Current guidelines from the European Society of Cardiology recommend LDL targets of below 1.8 mmol/L (70 mg/dL) for high-risk individuals and below 1.4 mmol/L (55 mg/dL) for very high-risk patients. Achieving these targets typically requires medication in addition to lifestyle modifications.

What Are Statins and How Do They Work?

Statins are the most widely prescribed cholesterol-lowering medications. They work by blocking an enzyme (HMG-CoA reductase) in the liver that produces cholesterol, leading to 30-50% reductions in LDL cholesterol. Common statins include atorvastatin (Lipitor), rosuvastatin (Crestor), and simvastatin (Zocor).

Statins have revolutionized the treatment of high cholesterol since the first statin, lovastatin, was approved in 1987. These medications work by inhibiting HMG-CoA reductase, the key enzyme in the cholesterol synthesis pathway in the liver. When the liver can no longer produce as much cholesterol, it compensates by pulling more LDL cholesterol out of the bloodstream, thereby lowering blood LDL levels.

Beyond their cholesterol-lowering effects, statins have additional cardiovascular benefits. They stabilize atherosclerotic plaques, making them less likely to rupture and cause heart attacks. They also have anti-inflammatory effects on blood vessel walls and may improve the function of the endothelium (the inner lining of blood vessels). These so-called "pleiotropic effects" contribute to the overall cardiovascular protection statins provide.

Large clinical trials involving over 170,000 participants have consistently shown that statin therapy reduces cardiovascular events. For every 1 mmol/L (39 mg/dL) reduction in LDL cholesterol, there is approximately a 22% relative reduction in major cardiovascular events over five years. This benefit has been demonstrated in both men and women, across all age groups, and in patients with or without existing heart disease.

Types of Statins

Statins are classified by their potency. High-intensity statins, which lower LDL by 50% or more, include atorvastatin 40-80mg and rosuvastatin 20-40mg. Moderate-intensity statins lower LDL by 30-50% and include atorvastatin 10-20mg, rosuvastatin 5-10mg, simvastatin 20-40mg, pravastatin 40-80mg, and lovastatin 40mg. Low-intensity statins lower LDL by less than 30%.

Common statins and their typical LDL-lowering effects
Statin (Generic Name) Brand Names Typical Dose Range Expected LDL Reduction
Atorvastatin Lipitor 10-80 mg daily 37-55%
Rosuvastatin Crestor 5-40 mg daily 45-63%
Simvastatin Zocor 10-40 mg daily 28-41%
Pravastatin Pravachol 10-80 mg daily 20-37%
Fluvastatin Lescol 20-80 mg daily 22-35%
Pitavastatin Livalo 1-4 mg daily 32-43%

Rosuvastatin and atorvastatin are generally considered the most potent statins and are typically the first choice for patients requiring significant LDL reductions. Pravastatin and fluvastatin have fewer drug interactions and may be preferred in patients taking multiple medications. Simvastatin should not be used at the 80mg dose due to increased muscle toxicity risk.

How to Take Statins

Most statins are taken once daily, with or without food. Simvastatin, lovastatin, and fluvastatin are best taken in the evening because the liver produces most cholesterol at night. Atorvastatin and rosuvastatin can be taken at any time of day since they have longer half-lives. Consistency in timing is more important than the specific time you choose.

It typically takes 2-4 weeks to see the full effect of statin therapy on cholesterol levels. Your doctor will usually recheck your lipid panel 6-12 weeks after starting treatment or changing doses. Regular monitoring helps ensure you're achieving your cholesterol goals and allows for dose adjustments if needed.

What Are the Side Effects of Cholesterol Medications?

The most common side effect of statins is muscle pain or weakness (myalgia), affecting 5-10% of users. Other side effects include headache, digestive issues, and rarely, elevated liver enzymes. Serious side effects like rhabdomyolysis (severe muscle breakdown) are very rare, occurring in about 1 in 10,000 patients.

Understanding the potential side effects of cholesterol medications helps you recognize problems early and work with your doctor to find solutions. Most side effects are mild and manageable, and the cardiovascular benefits of treatment typically far outweigh the risks for those who need these medications.

Muscle-Related Side Effects

Muscle symptoms are the most commonly reported side effects of statins. Myalgia (muscle pain or aching without elevated muscle enzymes) affects approximately 5-10% of statin users in clinical practice, though rates vary widely between studies. The pain is typically symmetrical, affecting both sides of the body equally, and often involves the thighs, buttocks, calves, and lower back.

More serious but rare muscle problems include myopathy (muscle pain with elevated creatine kinase levels) and rhabdomyolysis (severe muscle breakdown that can damage the kidneys). Rhabdomyolysis occurs in approximately 1-3 per 100,000 patient-years of statin use. Signs include severe muscle pain, weakness, and dark (cola-colored) urine. If you experience these symptoms, contact your doctor immediately.

Risk factors for muscle side effects include advanced age, small body frame, female sex, hypothyroidism, kidney or liver disease, high alcohol consumption, and certain drug interactions. Higher statin doses and some specific statins (particularly simvastatin at high doses) carry higher muscle risk.

When to Contact Your Doctor About Muscle Symptoms:
  • Unexplained muscle pain that is new since starting statin
  • Muscle weakness that interferes with daily activities
  • Muscle tenderness or cramping
  • Dark urine (sign of possible rhabdomyolysis)
  • Fever with muscle symptoms

Other Side Effects

Digestive symptoms including nausea, constipation, diarrhea, and abdominal pain occur in some patients but are usually mild and transient. Headaches may occur, particularly when starting treatment, but often resolve with continued use.

Statins can raise blood sugar levels slightly and may increase the risk of developing type 2 diabetes by approximately 10-12%. However, for most patients, the cardiovascular benefits of statin therapy far outweigh this small diabetes risk. The risk is highest in those already predisposed to diabetes.

Liver enzyme elevations occur in about 1-2% of statin users but are usually mild and reversible. Serious liver damage from statins is extremely rare. Current guidelines no longer recommend routine liver function monitoring unless symptoms develop, though baseline testing before starting treatment is reasonable.

Some patients report cognitive effects such as memory problems or confusion. Studies have not consistently shown statins cause cognitive impairment, and any effects appear to be rare and reversible upon stopping the medication. Importantly, statins may actually protect against dementia by improving cardiovascular health.

Managing Side Effects

If you experience side effects, do not stop taking your statin without consulting your doctor. There are several strategies to manage muscle symptoms while maintaining cholesterol treatment. These include reducing the dose, switching to a different statin (especially hydrophilic statins like pravastatin or rosuvastatin which may have fewer muscle effects), trying intermittent dosing (every other day for long-acting statins), or adding CoQ10 supplements (though evidence is mixed).

What Other Medications Are Available for High Cholesterol?

When statins alone are insufficient or not tolerated, other medications include ezetimibe (blocks cholesterol absorption), PCSK9 inhibitors (injectable antibodies that dramatically lower LDL), fibrates (primarily for high triglycerides), bile acid sequestrants, and bempedoic acid (a newer oral option for statin-intolerant patients).

Ezetimibe (Zetia)

Ezetimibe works differently from statins by blocking cholesterol absorption in the small intestine. It reduces LDL cholesterol by approximately 15-20% when used alone and provides additional 15-25% reduction when added to a statin. The IMPROVE-IT trial demonstrated that adding ezetimibe to statin therapy reduces cardiovascular events in patients with recent heart attacks.

Ezetimibe is well-tolerated with minimal side effects. It does not cause muscle pain and can be safely used in patients who cannot tolerate statins. It's also available in combination pills with statins (such as Vytorin, which combines ezetimibe with simvastatin).

PCSK9 Inhibitors

PCSK9 inhibitors represent a major advancement in cholesterol treatment. These injectable medications (evolocumab/Repatha and alirocumab/Praluent) can reduce LDL cholesterol by 50-60%, even when added to maximum statin therapy. They work by blocking a protein called PCSK9, which normally degrades the receptors that remove LDL from the blood.

Large clinical trials (FOURIER and ODYSSEY OUTCOMES) have demonstrated that PCSK9 inhibitors significantly reduce cardiovascular events, including heart attacks and strokes. They are particularly valuable for patients with familial hypercholesterolemia, statin intolerance, or those who cannot reach LDL goals with other treatments.

PCSK9 inhibitors are given as subcutaneous injections every 2-4 weeks. They are well-tolerated, with injection site reactions being the most common side effect. The main limitation is cost, though prices have decreased significantly since initial approval.

Inclisiran

Inclisiran (Leqvio) is a newer injectable medication that also targets PCSK9, but through a different mechanism called RNA interference (siRNA). It reduces LDL by approximately 50% and only requires injection every six months after initial dosing, making it much more convenient than PCSK9 antibodies. It was approved by the FDA in 2021 for patients with clinical cardiovascular disease or familial hypercholesterolemia who need additional LDL lowering.

Bempedoic Acid

Bempedoic acid (Nexletol) is an oral medication approved in 2020 that works in the same cholesterol-production pathway as statins but is activated only in the liver, not in muscle tissue. This means it can lower LDL without causing muscle side effects. It reduces LDL by approximately 15-25% and has been shown to reduce cardiovascular events in statin-intolerant patients.

Bempedoic acid is available alone or in combination with ezetimibe (Nexlizet). It's an important option for patients who cannot tolerate any statin due to muscle symptoms.

Fibrates

Fibrates (fenofibrate, gemfibrozil) primarily lower triglycerides by 30-50% and raise HDL cholesterol by 10-15%. They are most useful in patients with high triglycerides, particularly those with triglyceride levels above 500 mg/dL who are at risk for pancreatitis. Their role in reducing cardiovascular events is less well-established than statins.

Gemfibrozil should not be used with statins due to significantly increased risk of muscle damage. Fenofibrate can be used with statins more safely and is the preferred fibrate when combination therapy is needed.

Bile Acid Sequestrants

Bile acid sequestrants (cholestyramine, colesevelam, colestipol) are resins that bind bile acids in the intestine, preventing their reabsorption. This causes the liver to use more cholesterol to make new bile acids, thereby lowering blood cholesterol. They reduce LDL by 15-30% but can cause gastrointestinal side effects and interfere with absorption of other medications.

Non-statin medications for lowering cholesterol
Medication Type LDL Reduction Administration Best Used For
Ezetimibe 15-20% Once daily oral Add-on to statin; statin intolerance
PCSK9 Inhibitors 50-60% Injection every 2-4 weeks Familial hypercholesterolemia; very high risk
Inclisiran ~50% Injection every 6 months CVD or FH needing additional lowering
Bempedoic Acid 15-25% Once daily oral Statin intolerance with muscle symptoms
Fibrates 5-20% (mainly lowers triglycerides) Once daily oral High triglycerides

How Do Lifestyle Changes Work with Medication?

Lifestyle modifications including heart-healthy diet, regular exercise, weight management, and smoking cessation can reduce LDL cholesterol by 10-20% and enhance medication effectiveness. These changes are recommended for everyone with high cholesterol, whether or not they take medication, and may allow lower medication doses or, in some cases, prevent the need for drugs altogether.

Cholesterol medications work best when combined with a healthy lifestyle. While medication can achieve greater cholesterol reductions than lifestyle changes alone, the two approaches are synergistic. A heart-healthy lifestyle addresses multiple cardiovascular risk factors simultaneously, including blood pressure, blood sugar, weight, and inflammation.

Dietary Changes

A heart-healthy diet is the cornerstone of cholesterol management. The Mediterranean diet and DASH (Dietary Approaches to Stop Hypertension) diet have the strongest evidence for cardiovascular benefit. Key dietary recommendations include:

  • Reduce saturated fat: Limit red meat, full-fat dairy, and tropical oils (coconut, palm). Replace with unsaturated fats from olive oil, nuts, and fish.
  • Eliminate trans fats: Avoid partially hydrogenated oils found in some processed foods and baked goods.
  • Increase soluble fiber: Eat more oats, beans, apples, pears, and psyllium. Soluble fiber binds cholesterol in the digestive tract.
  • Add plant sterols and stanols: Found naturally in small amounts in vegetables, nuts, and grains. Fortified margarines and yogurts can provide therapeutic doses.
  • Eat fatty fish: Two servings per week provide omega-3 fatty acids that lower triglycerides and have anti-inflammatory effects.
  • Limit dietary cholesterol: While less impactful than saturated fat, limiting egg yolks and organ meats is still reasonable.

Diet alone can typically lower LDL by 10-15%. For some individuals, particularly those with mildly elevated cholesterol and no other major risk factors, dietary changes may be sufficient without medication.

Exercise and Physical Activity

Regular physical activity has multiple cardiovascular benefits. While exercise has modest effects on LDL cholesterol (typically 3-6% reduction), it significantly increases HDL cholesterol, lowers triglycerides, improves blood pressure, helps with weight management, and reduces inflammation.

Current guidelines recommend at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of vigorous activity per week, preferably spread throughout the week. Resistance training 2-3 times per week provides additional benefits. Even small amounts of activity are better than none, and any increase from your current level is beneficial.

Weight Management

Excess body weight, particularly abdominal obesity, is associated with higher LDL cholesterol, lower HDL cholesterol, and elevated triglycerides. Losing 5-10% of body weight can improve all aspects of your lipid profile and may allow medication dose reductions. Weight loss also improves blood pressure and blood sugar control.

Smoking Cessation

Smoking damages blood vessels, accelerates atherosclerosis, and lowers HDL cholesterol. Quitting smoking is one of the most impactful changes you can make for cardiovascular health. Within one year of quitting, excess cardiovascular risk from smoking is reduced by half.

What About Special Situations?

Special populations including older adults, pregnant women, children with familial hypercholesterolemia, and people with kidney or liver disease may require modified approaches to cholesterol treatment. Decisions should be individualized based on overall health status, life expectancy, and personal preferences.

Older Adults

Statin therapy remains beneficial in older adults. Meta-analyses have shown that people over 75 benefit from statins for secondary prevention (after a heart attack or stroke). For primary prevention in very elderly patients, the decision is more nuanced and should consider overall health, life expectancy, polypharmacy, and patient preferences. Lower starting doses and careful monitoring are advisable.

Pregnancy and Breastfeeding

Statins are contraindicated during pregnancy due to potential risks to fetal development. Women planning pregnancy should stop statins ideally 1-2 months before conception. Cholesterol naturally rises during pregnancy and does not require treatment in most cases. After pregnancy, statins are generally avoided during breastfeeding, though data is limited. Women with familial hypercholesterolemia or very high risk may require specialized management.

Familial Hypercholesterolemia

Familial hypercholesterolemia (FH) is a genetic condition causing extremely high LDL cholesterol from birth. It affects about 1 in 250 people and dramatically increases cardiovascular risk. Patients with FH typically require aggressive treatment with high-intensity statins often combined with ezetimibe and/or PCSK9 inhibitors. Treatment may begin in childhood, with screening recommended by age 2 for children with affected parents.

Kidney Disease

Patients with chronic kidney disease have increased cardiovascular risk but may metabolize statins differently. Dose adjustments may be needed for some statins. Rosuvastatin, atorvastatin, and fluvastatin do not require dose adjustment for mild-moderate kidney impairment. Avoid simvastatin and lovastatin at high doses in significant kidney disease.

Liver Disease

Statins are contraindicated in active liver disease or unexplained persistent liver enzyme elevations. However, patients with non-alcoholic fatty liver disease (NAFLD) may actually benefit from statin therapy, as their cardiovascular risk is elevated. Careful monitoring is recommended.

How Is Treatment Monitored?

After starting cholesterol medication, a follow-up lipid panel is typically done at 6-12 weeks to assess response. Once stable, annual testing is usually sufficient. Your doctor may also monitor liver enzymes, particularly when starting treatment, and watch for symptoms of muscle problems.

Regular monitoring ensures your treatment is effective and safe. The primary goal is achieving your LDL target, which varies based on your cardiovascular risk level. Very high-risk patients should aim for LDL below 1.4 mmol/L (55 mg/dL), while high-risk patients target below 1.8 mmol/L (70 mg/dL).

Lipid Panel Monitoring

After starting or changing cholesterol medication, a repeat lipid panel is typically done at 6-12 weeks. This allows time for the medication to reach full effect and provides data to guide dose adjustments. Once you're at target and stable, annual lipid testing is usually sufficient. More frequent testing may be needed if your risk status changes or if you're having difficulty reaching goals.

Liver Function Monitoring

While routine liver enzyme monitoring is no longer considered mandatory, baseline testing before starting statin therapy is reasonable. Testing should be done if you develop symptoms suggesting liver problems, such as unexplained fatigue, loss of appetite, upper abdominal pain, or jaundice (yellowing of skin or eyes).

Muscle Symptom Monitoring

Routine measurement of creatine kinase (CK) levels is not recommended unless you develop muscle symptoms. If you experience unexplained muscle pain, weakness, or tenderness, your doctor may check CK levels to assess for myopathy. If levels are markedly elevated (more than 10 times normal) with symptoms, the statin should be stopped.

Questions to Ask Your Doctor at Follow-Up:
  • Have I reached my cholesterol target?
  • Do I need any medication adjustments?
  • Should I continue the same lifestyle changes?
  • When should I have my next cholesterol check?
  • Are there any new treatment options I should consider?

What Drug Interactions Should I Know About?

Certain medications and even some foods can interact with cholesterol drugs, potentially increasing side effects or reducing effectiveness. Notable interactions include grapefruit juice with some statins, certain antibiotics and antifungals, blood thinners, and some HIV medications. Always inform your doctor about all medications and supplements you take.

Drug interactions with statins primarily occur because many statins are metabolized by the same liver enzymes (cytochrome P450, particularly CYP3A4). Drugs that inhibit or induce these enzymes can significantly affect statin blood levels.

Grapefruit Juice

Grapefruit juice inhibits CYP3A4 in the intestinal wall, which can significantly increase blood levels of atorvastatin, lovastatin, and simvastatin. This increases the risk of side effects, particularly muscle problems. Rosuvastatin, pravastatin, and fluvastatin are not significantly affected. If you regularly consume grapefruit, discuss this with your doctor.

Other Important Interactions

Several drug classes can interact with statins:

  • Fibrates: Gemfibrozil significantly increases statin muscle toxicity risk. Fenofibrate is safer with statins.
  • Macrolide antibiotics: Erythromycin and clarithromycin can increase statin levels. Azithromycin is a safer alternative.
  • Antifungals: Itraconazole and ketoconazole interact with CYP3A4-metabolized statins.
  • Calcium channel blockers: Diltiazem and verapamil can increase simvastatin and lovastatin levels.
  • HIV protease inhibitors: Many interact with statins; pravastatin and pitavastatin are preferred options.
  • Warfarin: Some statins can increase warfarin effect, requiring closer INR monitoring.
  • Cyclosporine: Significantly increases statin levels; use lowest possible statin doses.

Always provide your doctor with a complete list of all medications, including over-the-counter drugs and supplements. Pharmacists can also help identify potential interactions.

Frequently Asked Questions

The most common side effects of statins include muscle pain or weakness (myalgia), which affects about 5-10% of users. Other side effects can include headache, digestive problems, and rarely, increased liver enzymes. Serious side effects like rhabdomyolysis (severe muscle breakdown) are very rare, occurring in about 1 in 10,000 patients. Most people tolerate statins well, and the cardiovascular benefits typically outweigh the risks for those who need them.

Cholesterol medication is typically a long-term or lifelong treatment. High cholesterol is usually a chronic condition, and stopping medication often causes cholesterol levels to return to pre-treatment levels within weeks. However, significant lifestyle changes (diet, exercise, weight loss) may allow some patients to reduce their dosage under medical supervision. Never stop taking cholesterol medication without consulting your doctor.

Yes, lifestyle changes can lower cholesterol significantly. A heart-healthy diet low in saturated fats, regular exercise (at least 150 minutes per week), maintaining a healthy weight, quitting smoking, and limiting alcohol can reduce LDL cholesterol by 10-20%. However, for people with very high cholesterol, genetic factors, or existing cardiovascular disease, lifestyle changes alone are usually not enough, and medication is necessary to reach target levels.

LDL (low-density lipoprotein) is often called "bad" cholesterol because it deposits cholesterol in artery walls, leading to atherosclerosis. HDL (high-density lipoprotein) is called "good" cholesterol because it helps remove cholesterol from arteries and transport it back to the liver. Healthy targets are LDL below 100 mg/dL (2.6 mmol/L) for most people, or below 70 mg/dL (1.8 mmol/L) for high-risk individuals, and HDL above 40 mg/dL (1.0 mmol/L) for men or 50 mg/dL (1.3 mmol/L) for women.

Some natural supplements may have modest cholesterol-lowering effects. Plant sterols and stanols can reduce LDL by about 6-15%. Soluble fiber (psyllium, oat beta-glucan) can lower LDL by 5-10%. Red yeast rice contains a natural statin but varies in potency and quality. However, these supplements are generally less effective than prescription medications and should not replace prescribed treatment for high-risk individuals. Always discuss supplements with your doctor, especially if taking other medications.

Some patients report memory issues while taking statins, but large studies have not shown a consistent link between statins and cognitive decline. Any memory effects appear to be rare and reversible upon stopping the medication. In fact, by improving cardiovascular health, statins may actually protect against vascular dementia. The FDA has added a warning about possible memory effects, but this does not mean statins cause dementia. If you experience cognitive changes, discuss them with your doctor.

References

  1. Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020;41(1):111-188. doi:10.1093/eurheartj/ehz455
  2. Grundy SM, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143. doi:10.1161/CIR.0000000000000625
  3. Cholesterol Treatment Trialists' Collaboration. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet. 2019;393(10170):407-415.
  4. Taylor F, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews. 2023. doi:10.1002/14651858.CD004816.pub6
  5. Sabatine MS, et al. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease (FOURIER). New England Journal of Medicine. 2017;376(18):1713-1722.
  6. Ray KK, et al. Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol (ORION-10 and ORION-11). New England Journal of Medicine. 2020;382(16):1507-1519.
  7. Nissen SE, et al. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients (CLEAR Outcomes). New England Journal of Medicine. 2023;388(15):1353-1364.
  8. World Health Organization. Global Health Estimates 2020: Deaths by Cause, Age, Sex. WHO; 2021.

Editorial Team

This article was written and reviewed by the iMedic Medical Editorial Team, consisting of licensed physicians with specialization in cardiology, internal medicine, and preventive medicine.

Medical Writer

iMedic Medical Editorial Team

Specialists in Cardiology and Internal Medicine

Medical Reviewer

iMedic Medical Review Board

Independent panel following ESC/EAS and AHA/ACC guidelines

All content is reviewed according to international guidelines from the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS), American Heart Association (AHA), and American College of Cardiology (ACC). Last reviewed: .